OptimizeRx Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.13 | -$0.12 | -$0.13 |
| Q2 2024 | 1 | -$0.07 | -$0.06 | -$0.06 |
| Q3 2024 | 2 | $0.06 | $0.06 | $0.06 |
| Q4 2024 | 6 | $0.24 | $0.27 | $0.25 |
| Q1 2025 | 3 | -$0.04 | -$0.03 | -$0.04 |
| Q2 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 2 | $0.07 | $0.08 | $0.08 |
| Q4 2025 | 2 | $0.30 | $0.32 | $0.31 |
OptimizeRx Corporation Earnings Date And Information
OptimizeRx Corporation last posted its earnings results on Wednesday, November 13th, 2024. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.06. The company had revenue of 21.31 M for the quarter and had revenue of 71.52 M for the year. OptimizeRx Corporation has generated $-1 earnings per share over the last year ($-1.03 diluted earnings per share) and currently has a price-to-earnings ratio of -3.69. OptimizeRx Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
OptimizeRx Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.50 | $24.99 M | $21.31 M | ||
| 08/15/2024 | Q2 2024 | -$0.22 | $20.16 M | $18.81 M | ||
| 05/15/2024 | Q1 2024 | -$0.38 | $19.69 M | |||
| 04/15/2024 | Q4 2023 | -$0.23 | $28.37 M | |||
| 11/06/2023 | Q3 2023 | $0.03 | -$0.17 | -0.2 | $15.14 M | $16.33 M |
| 08/14/2023 | Q2 2023 | -$0.01 | -$0.24 | -0.23 | $14.80 M | $13.82 M |
| 05/12/2023 | Q1 2023 | -$0.37 | $13.00 M | |||
| 03/10/2023 | Q4 2022 | $0.01 | $19.65 M | |||
| 03/10/2023 | Q3 2022 | -$0.18 | $14.92 M | $15.09 M | ||
| 03/10/2023 | Q2 2022 | -$0.21 | $17.06 M | $13.98 M | ||
| 03/10/2023 | Q1 2022 | -$0.21 | $13.73 M | |||
| 03/10/2023 | Q4 2021 | $0.04 | $20.31 M | |||
| 11/09/2021 | Q3 2021 | $0.13 | $0.00 | -0.13 | $15.14 M | $16.12 M |
| 08/04/2021 | Q2 2021 | $0.07 | $0.02 | -0.05 | $12.45 M | $13.63 M |
| 05/06/2021 | Q1 2021 | $0.01 | -$0.04 | -0.05 | $11.23 M | |
| 03/08/2021 | Q4 2020 | $0.09 | $16.43 M | |||
| 11/09/2020 | Q3 2020 | $0.04 | -$0.02 | -0.06 | $9.77 M | $10.52 M |
| 08/05/2020 | Q2 2020 | $0.01 | -$0.07 | -0.08 | $7.97 M | $8.78 M |
| 05/06/2020 | Q1 2020 | -$0.15 | $7.58 M | |||
| 03/26/2020 | Q4 2019 | -$0.14 | $7.38 M |
OptimizeRx Corporation Earnings: Frequently Asked Questions
-
When is OptimizeRx Corporation's earnings date?
OptimizeRx Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did OptimizeRx Corporation beat their earnings estimates last quarter?
In the previous quarter, OptimizeRx Corporation (:OPRX) reported $0.12 earnings per share (EPS) to beat the analysts' consensus estimate of $0.06 by $0.06.
-
How can I listen to OptimizeRx Corporation's earnings conference call?
The conference call for OptimizeRx Corporation's latest earnings report can be listened to online.
-
How can I read OptimizeRx Corporation's conference call transcript?
The conference call transcript for OptimizeRx Corporation's latest earnings report can be read online.
-
How much revenue does OptimizeRx Corporation generate each year?
OptimizeRx Corporation (:OPRX) has a recorded annual revenue of $71.52 M.
-
How much profit does OptimizeRx Corporation generate each year?
OptimizeRx Corporation (:OPRX) has a recorded net income of $71.52 M. OptimizeRx Corporation has generated $-1.03 earnings per share over the last four quarters.
-
What is OptimizeRx Corporation's price-to-earnings ratio?
OptimizeRx Corporation (:OPRX) has a price-to-earnings ratio of -3.69 and price/earnings-to-growth ratio is 0.11.
